Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat, Melphalan, and Prednisone for Advanced Multiple Myeloma
NCT00857324Phase 2Terminated
- Start
- Mar 2009
- Primary completion
- Mar 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in multiple myeloma (MM). Started Mar 2009; status: terminated.
02
Drugs
vorinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00857324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857324.